반응식
[C:1]([OH:10])(=O)[C:2]1[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=1)[NH2:4].[CH3:11][NH2:12].[OH:13][C:14]1[CH:21]=[CH:20][C:17]([CH:18]=O)=[C:16]([O:22][CH3:23])[CH:15]=1.Cl[CH2:25][CH2:26][CH2:27]Br.[CH3:29][C@H:30]1[CH2:35][CH2:34][CH2:33][NH:32][CH2:31]1.C([O-])(=O)[C@@H](C1C=CC=CC=1)O>>[CH3:23][O:22][C:16]1[CH:15]=[C:14]([O:13][CH2:25][CH2:26][CH2:27][N:32]2[CH2:33][CH2:34][CH2:35][C@H:30]([CH3:29])[CH2:31]2)[CH:21]=[CH:20][C:17]=1[C:18]1[N:12]([CH3:11])[C:1](=[O:10])[C:2]2[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=2)[N:4]=1참가 물질
7
실험 절차
The entitled compound was obtained according to the method of Example 1 but starting from anthranilic acid, methylamine, 4-hydroxy-2-methoxybenzaldehyde, 1-chloro-3-bromopropane and (3S)-3-methylpiperidine.(R)-mandelate.
후처리
- customThe entitled compound was obtained
출처 및 근거
- ORD 기록
- ord-d9c3f9ea6a474542981abb432eb5cb2e
- 출처 데이터셋
- uspto-grants-2011_06
- 특허 번호
- US07960394B2
연결된 노트
불러오는 중…